TransMedics (TMDX) Cash from Financing Activities (2018 - 2026)

TransMedics' Cash from Financing Activities history runs 9 years deep, the most recent figure standing at $3.8 million for Q1 2026.

• In Q1 2026, Cash from Financing Activities rose 24.24% year-over-year to $3.8 million; the TTM figure through Mar 2026 stood at $17.6 million (down 22.56% YoY), while the FY2025 annual figure was $16.9 million, down 26.3% from the prior year.
• Cash from Financing Activities was $3.8 million for Q1 2026 at TransMedics, up from $3.1 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $394.0 million in Q2 2023 to a low of $237000.0 in Q2 2022.
• Historically, Cash from Financing Activities has averaged $36.0 million across 5 years, with a median of $3.2 million in 2024.
• Biggest YoY gain for Cash from Financing Activities was 166150.21% in 2023; the steepest drop was 99.07% in 2023.
• A 5-year view of Cash from Financing Activities shows it stood at $3.1 million in 2022, then plunged by 69.85% to $924000.0 in 2023, then rose by 28.35% to $1.2 million in 2024, then soared by 161.3% to $3.1 million in 2025, then advanced by 21.39% to $3.8 million in 2026.
• The last three Cash from Financing Activities figures came in at $3.8 million (Q1 2026), $3.1 million (Q4 2025), and $3.6 million (Q3 2025), per Business Quant data.